{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:26:49Z","timestamp":1787740009101,"version":"build-2784847793"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011493","name":"Taizhou Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.omtn.2025.102471","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T02:32:43Z","timestamp":1738377163000},"page":"102471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The applications of live attenuated influenza a virus with modified NS1 gene"],"prefix":"10.1016","volume":"36","author":[{"given":"Hongbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4717-0747","authenticated-orcid":false,"given":"Ze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102471_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2094","article-title":"Live Attenuated and Inactivated Influenza Vaccine Effectiveness","volume":"143","author":"Chung","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtn.2025.102471_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00006454-200301000-00010","article-title":"Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children","volume":"22","author":"Bernstein","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.omtn.2025.102471_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9091032","article-title":"An Overview of Influenza Viruses and Vaccines","volume":"9","author":"Nuwarda","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.omtn.2025.102471_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vaccine.2015.11.010","article-title":"Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102471_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023118","article-title":"Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink","volume":"8","author":"Caspard","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.omtn.2025.102471_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1222805","article-title":"NS1 and PA-X of H1N1\/09 influenza virus act in a concerted manner to manipulate the innate immune response of porcine respiratory epithelial cells","volume":"13","author":"Avanthay","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omtn.2025.102471_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chom.2009.04.006","article-title":"Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I","volume":"5","author":"Gack","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2025.102471_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.670177","article-title":"NS1: A Key Protein in the \"Game\" Between Influenza A Virus and Host in Innate Immunity","volume":"11","author":"Ji","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omtn.2025.102471_bib9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0021-9258(17)49923-6","article-title":"The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I","volume":"295","author":"Jureka","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2025.102471_bib10","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.vaccine.2021.02.077","article-title":"Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge","volume":"39","author":"Lee","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102471_bib11","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.01920-08","article-title":"Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza","volume":"83","author":"Steel","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib12","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1073\/pnas.070525997","article-title":"Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach","volume":"97","author":"Talon","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102471_bib13","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1128\/JVI.01565-14","article-title":"Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development","volume":"88","author":"Nogales","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bmc.2011.10.026","article-title":"Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1","volume":"20","author":"Jablonski","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omtn.2025.102471_bib15","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1128\/JVI.78.18.10149-10155.2004","article-title":"Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence","volume":"78","author":"Iwatsuki-Horimoto","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib16","article-title":"An NS-segment exonic splicing enhancer regulates influenza A virus replication in mammalian cells","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102471_bib17","article-title":"Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule Drugs","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102471_bib18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/ijms21041511","article-title":"The Central Role of Non-Structural Protein 1 (NS1) in Influenza Biology and Infection","volume":"21","author":"Rosario-Ferreira","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102471_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.antiviral.2013.06.005","article-title":"The influenza virus NS1 protein as a therapeutic target","volume":"99","author":"Engel","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.omtn.2025.102471_bib20","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1128\/JVI.03692-13","article-title":"The influenza A virus protein NS1 displays structural polymorphism","volume":"88","author":"Carrillo","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003440","article-title":"The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication","volume":"9","author":"de Chassey","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2025.102471_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/JVI.06519-11","article-title":"A second CRM1-dependent nuclear export signal in the influenza A virus NS2 protein contributes to the nuclear export of viral ribonucleoproteins","volume":"87","author":"Huang","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2015.01.007","article-title":"Functions of the influenza A virus NS1 protein in antiviral defense","volume":"12","author":"Krug","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2006.01.005","article-title":"Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA","volume":"349","author":"Li","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2025.102471_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02168-18","article-title":"The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4","volume":"93","author":"Dubois","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib26","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1128\/JVI.01667-08","article-title":"Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells","volume":"83","author":"Hsiang","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib27","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/JVI.02063-12","article-title":"SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization","volume":"87","author":"Santos","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.6026\/97320630002057","article-title":"Identification of a casein kinase II phosphorylation domain in NS1 protein of H5N1 influenza virus","volume":"2","author":"Anwar","year":"2007","journal-title":"Bioinformation"},{"key":"10.1016\/j.omtn.2025.102471_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virol.2008.10.002","article-title":"CDK\/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215","volume":"383","author":"Hale","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2025.102471_bib30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cmi.12559","article-title":"Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity","volume":"18","author":"Kathum","year":"2016","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.omtn.2025.102471_bib31","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/1873-3468.12311","article-title":"NF90 is a novel influenza A virus NS1-interacting protein that antagonizes the inhibitory role of NS1 on PKR phosphorylation","volume":"590","author":"Li","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2025.102471_bib32","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1099\/vir.0.009050-0","article-title":"Influenza A virus proteins PB1 and NS1 are subject to functionally important phosphorylation by protein kinase C","volume":"90","author":"Mahmoudian","year":"2009","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02369-20","article-title":"Phosphorylation of Influenza A Virus NS1 at Serine 205 Mediates Its Viral Polymerase-Enhancing Function","volume":"95","author":"Patil","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib34","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1128\/JVI.02562-10","article-title":"The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes","volume":"85","author":"Robb","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib35","doi-asserted-by":"crossref","first-page":"e12643","DOI":"10.1111\/cmi.12643","article-title":"Threonine 80 phosphorylation of non-structural protein 1 regulates the replication of influenza A virus by reducing the binding affinity with RIG-I","volume":"19","author":"Zheng","year":"2017","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.omtn.2025.102471_bib36","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-022-01245-y","article-title":"Protein acylation: mechanisms, biological functions and therapeutic targets","volume":"7","author":"Shang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.omtn.2025.102471_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13567-020-00747-3","article-title":"Acetylation at K108 of the NS1 protein is important for the replication and virulence of influenza virus","volume":"51","author":"Ma","year":"2020","journal-title":"Vet. Res."},{"key":"10.1016\/j.omtn.2025.102471_bib38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K Pathway in Human Disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2025.102471_bib39","article-title":"A Comprehensive Analysis of the PI3K\/AKT Pathway: Unveiling Key Proteins and Therapeutic Targets for Cancer Treatment","volume":"22","author":"Fadhal","year":"2023","journal-title":"Cancer Inf."},{"key":"10.1016\/j.omtn.2025.102471_bib40","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1128\/JVI.02082-06","article-title":"Influenza A virus NS1 protein activates the PI3K\/Akt pathway to mediate antiapoptotic signaling responses","volume":"81","author":"Ehrhardt","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib41","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1128\/JVI.74.13.6203-6206.2000","article-title":"Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication","volume":"74","author":"Bergmann","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/v15102063","article-title":"Structural Investigations of Interactions between the Influenza a Virus NS1 and Host Cellular Proteins","volume":"15","author":"Blake","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2025.102471_bib98","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02196-21","article-title":"The Effector Domain of the Influenza A Virus Nonstructural Protein NS1 Triggers Host Shutoff by Mediating Inhibition and Global Deregulation of Host Transcription When Associated with Specific Structures in the Nucleus","volume":"12","author":"Nacken","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.omtn.2025.102471_bib99","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1099\/vir.0.19487-0","article-title":"PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes","volume":"84","author":"Burgui","year":"2003","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature10892","article-title":"Suppression of the antiviral response by an influenza histone mimic","volume":"483","author":"Marazzi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102471_bib101","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00198-17","article-title":"Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR","volume":"91","author":"Schierhorn","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib102","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2007.01.038","article-title":"A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis","volume":"363","author":"Min","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2025.102471_bib103","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1462-5822.2009.01309.x","article-title":"A new player in a deadly game: influenza viruses and the PI3K\/Akt signalling pathway","volume":"11","author":"Ehrhardt","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.omtn.2025.102471_bib104","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1128\/JVI.00126-14","article-title":"Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression","volume":"88","author":"Wang","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib105","doi-asserted-by":"crossref","first-page":"10639","DOI":"10.1128\/JVI.05070-11","article-title":"The avian influenza virus NS1 ESEV PDZ binding motif associates with Dlg1 and Scribble to disrupt cellular tight junctions","volume":"85","author":"Golebiewski","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib106","doi-asserted-by":"crossref","first-page":"11164","DOI":"10.1128\/JVI.01278-10","article-title":"The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble","volume":"84","author":"Liu","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2022.110483","article-title":"H3N2 canine influenza virus NS1 protein inhibits canine NLRP3 inflammasome activation","volume":"252","author":"Tao","year":"2022","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.omtn.2025.102471_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.778950","article-title":"NLRP3 Inflammasome Activation Enhanced by TRIM25 is Targeted by the NS1 Protein of 2009 Pandemic Influenza A Virus","volume":"12","author":"Park","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtn.2025.102471_bib42","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/nar\/gku1289","article-title":"A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1","volume":"43","author":"Vachon","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102471_bib43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.str.2015.03.012","article-title":"The Activation Mechanism of 2'-5'-Oligoadenylate Synthetase Gives New Insights Into OAS\/cGAS Triggers of Innate Immunity","volume":"23","author":"Lohofener","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.omtn.2025.102471_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4168\/aair.2022.14.1.99","article-title":"OASL1-Mediated Inhibition of Type I IFN Reduces Influenza A Infection-Induced Airway Inflammation by Regulating ILC2s","volume":"14","author":"Chang","year":"2022","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.omtn.2025.102471_bib46","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1515\/BC.2008.148","article-title":"Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy","volume":"389","author":"Ludwig","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.omtn.2025.102471_bib47","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1128\/JVI.02843-15","article-title":"Role of N Terminus-Truncated NS1 Proteins of Influenza A Virus in Inhibiting IRF3 Activation","volume":"90","author":"Kuo","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib48","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1128\/JVI.80.8.3957-3965.2006","article-title":"The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target","volume":"80","author":"Twu","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib49","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/emboj\/18.8.2273","article-title":"Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery","volume":"18","author":"Chen","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2025.102471_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121205","article-title":"Characterization of a novel mutation in NS1 protein of influenza A virus induced by a chemical substance for the attenuation of pathogenicity","volume":"10","author":"Sasaki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102471_bib108","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/JVI.01698-07","article-title":"A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice","volume":"82","author":"Jiao","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/v9050107","article-title":"A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection","volume":"9","author":"Wang","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2025.102471_bib110","doi-asserted-by":"crossref","first-page":"12761","DOI":"10.1128\/JVI.00701-10","article-title":"Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response","volume":"84","author":"Steidle","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib111","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01930-16","article-title":"NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses","volume":"91","author":"Nogales","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib85","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02180-19","article-title":"Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines","volume":"10","author":"Wang","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.omtn.2025.102471_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13567-016-0400-7","article-title":"Attenuation of the virulence of a recombinant influenza virus expressing the naturally truncated NS gene from an H3N8 equine influenza virus in mice","volume":"47","author":"Na","year":"2016","journal-title":"Vet. Res."},{"key":"10.1016\/j.omtn.2025.102471_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005984","article-title":"Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine","volume":"4","author":"Romanova","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102471_bib56","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2008.05.001","article-title":"Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102471_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2016.10.008","article-title":"Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines","volume":"500","author":"Nogales","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2025.102471_bib58","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3389\/fmicb.2017.01086","article-title":"Efficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza Viruses","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omtn.2025.102471_bib61","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1016\/j.vaccine.2015.09.048","article-title":"Optimal attenuation of a PR8-derived mouse pathogenic H5N1 recombinant virus for testing antigenicity and protective efficacy in mice","volume":"33","author":"Kim","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102471_bib112","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1128\/JVI.00410-16","article-title":"Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines","volume":"90","author":"Nogales","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib63","first-page":"720","article-title":"[Rescued influenza A virus with codon deoptimized NS1 gene is attenuated both in\u00a0vitro and in\u00a0vivo]","volume":"25","author":"Luan","year":"2009","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"10.1016\/j.omtn.2025.102471_bib51","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1128\/JVI.01131-12","article-title":"NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge","volume":"86","author":"Pica","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib52","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2022.03.051","article-title":"Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages","volume":"40","author":"Vandoorn","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102471_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00705-016-2966-9","article-title":"A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in\u00a0vitro","volume":"162","author":"Lee","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib57","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/mt.2016.23","article-title":"H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets","volume":"24","author":"de Jonge","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102471_bib59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature04378","article-title":"Architecture of ribonucleoprotein complexes in influenza A virus particles","volume":"439","author":"Noda","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102471_bib60","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1128\/JVI.79.12.7535-7543.2005","article-title":"Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs","volume":"79","author":"Solorzano","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib64","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.jmb.2019.04.021","article-title":"Codon and Codon-Pair Usage Tables\u00a0(CoCoPUTs): Facilitating Genetic Variation Analyses and Recombinant Gene Design","volume":"431","author":"Alexaki","year":"2019","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtn.2025.102471_bib65","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.vaccine.2015.11.054","article-title":"Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets","volume":"34","author":"Broadbent","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102471_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107586","article-title":"Mechanism of Virus Attenuation by Codon Pair Deoptimization","volume":"31","author":"Groenke","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2025.102471_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/v10120708","article-title":"Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins","volume":"10","author":"Nogales","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2025.102471_bib68","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.1128\/JVI.00006-07","article-title":"The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells","volume":"81","author":"Twu","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vetimm.2015.03.003","article-title":"Mitochondrial antiviral signaling adaptor mediated apoptosis in H3N2 swine influenza virus infection is inhibited by viral protein NS1 in\u00a0vitro","volume":"165","author":"Zhang","year":"2015","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.omtn.2025.102471_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/524165","article-title":"Dose- and time-dependent apoptosis induced by avian H9N2 influenza virus in human cells","volume":"2013","author":"Shahsavandi","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.omtn.2025.102471_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1743-422X-8-181","article-title":"The NS1 protein of influenza A virus interacts with heat shock protein Hsp90 in human alveolar basal epithelial cells: implication for virus-induced apoptosis","volume":"8","author":"Zhang","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2025.102471_bib72","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2014.01.022","article-title":"Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB\/c mice","volume":"104","author":"Bian","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.omtn.2025.102471_bib73","first-page":"558","article-title":"Evaluation of the immunotoxicity and allergenicity of a new intranasal influenza vector vaccine against tuberculosis carrying TB10.4 and HspX antigens","volume":"26","author":"Stosman","year":"2023","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.omtn.2025.102471_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040394","article-title":"Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs","volume":"9","author":"Sergeeva","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.omtn.2025.102471_bib75","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41467-023-37697-1","article-title":"An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters","volume":"14","author":"Deng","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102471_bib76","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1073\/pnas.1904022116","article-title":"Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer","volume":"117","author":"Newman","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102471_bib77","first-page":"8188","article-title":"A genetically engineered influenza A virus with ras-dependent oncolytic properties","volume":"61","author":"Bergmann","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2025.102471_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ijc.20078","article-title":"Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants","volume":"110","author":"Muster","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2025.102471_bib79","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/JVI.80.1.383-394.2006","article-title":"Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells","volume":"80","author":"Efferson","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2025.102471_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036506","article-title":"Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame","volume":"7","author":"van Rikxoort","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102471_bib81","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.surg.2016.08.045","article-title":"Oncolytic influenza A virus expressing interleukin-15 decreases tumor growth in\u00a0vivo","volume":"161","author":"Hock","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.omtn.2025.102471_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.954811","article-title":"Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use","volume":"12","author":"Nogales","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omtn.2025.102471_bib83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2018.01.005","article-title":"Development of a novel equine influenza virus live-attenuated vaccine","volume":"516","author":"Rodriguez","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2025.102471_bib84","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1040638720907918","article-title":"Detection of live attenuated influenza vaccine virus and evidence of reassortment in the U.S. swine population","volume":"32","author":"Sharma","year":"2020","journal-title":"J.\u00a0Vet. Diagn. Invest."},{"key":"10.1016\/j.omtn.2025.102471_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/bioe.21950","article-title":"Engineering influenza viral vectors","volume":"4","author":"Li","year":"2013","journal-title":"Bioengineered"},{"key":"10.1016\/j.omtn.2025.102471_bib87","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/s41467-023-39560-9","article-title":"Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102471_bib88","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/j.vaccine.2013.05.080","article-title":"Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines","volume":"31","author":"Jang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102471_bib89","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/162.2.394","article-title":"Comparison of live attenuated cold-adapted and avian-human influenza A\/Bethesda\/85 (H3N2) reassortant virus vaccines in infants and children","volume":"162","author":"Steinhoff","year":"1990","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102471_bib90","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038653","article-title":"Live Attenuated Cold-Adapted Influenza Vaccines","volume":"11","author":"Subbarao","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.omtn.2025.102471_bib91","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/vaccines8030464","article-title":"Next Generation Influenza Vaccines: Looking into the Crystal Ball","volume":"8","author":"Guzman","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.omtn.2025.102471_bib92","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038448","article-title":"Next-Generation Influenza Vaccines","volume":"11","author":"Kanekiyo","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.omtn.2025.102471_bib93","first-page":"312","article-title":"Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal","volume":"4","year":"2003","journal-title":"Drugs R"},{"key":"10.1016\/j.omtn.2025.102471_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11081391","article-title":"Advances in Adjuvanted Influenza Vaccines","volume":"11","author":"Shichinohe","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.omtn.2025.102471_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010068","article-title":"Promising Adjuvants and Platforms for Influenza Vaccine Development","volume":"13","author":"Zhu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2025.102471_bib96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s44149-022-00051-x","article-title":"Evaluating alpha-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs","volume":"2","author":"Artiaga","year":"2022","journal-title":"Anim. Dis."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125000253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125000253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:24:59Z","timestamp":1762601099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125000253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2162253125000253"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102471","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The applications of live attenuated influenza a virus with modified NS1 gene","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102471"}}